Introduction: Heart failure (HF) with preserved ejection fraction (EF)(HFpEF) accounts for
approximately 50% of HF cases and its prevalence relative to HF with reduced EF is rising …

Hypertension is a major contributor to the development of heart failure with preserved
ejection fraction (HFpEF). Our understanding of the epidemiology and pathophysiology of …

Abstract Purpose of Review Hypertension heralds the diagnosis of heart failure (HF) with
preserved ejection fraction (HFpEF) in 75–85% of cases and shares many of its adverse …

Hypertension constitutes a major risk factor for heart failure with preserved ejection fraction
(HFpEF). HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity …

There is a current epidemic of congestive heart failure (CHF) throughout the world, including
Korea, where its current prevalence in adults is 1% to 3%. 1 The prevalence of HF in Korea …

Heart failure with preserved ejection fraction in hypertensi... : Current Opinion in Cardiology
Heart failure with preserved ejection fraction in hypertension : Current Opinion in Cardiology Log …

Heart failure with preserved ejection fraction (HFpEF) is a prevalent but incompletely
understood syndrome. Traditional models of HFpEF pathophysiology revolve around …

Heart failure with preserved ejection fraction (HFpEF) is an entity that still raises many
questions. The agreement about definition, pathophysiology, and therapeutic approach is …

Heart failure with preserved ejection fraction (HFpEF) is now recognized as a major and
growing public health problem worldwide. Yet significant uncertainties still surround its …

The nexus of HTN and HFpEF remains strong and complex. Although traditional
medications for treating HFrEF did not affect long-term outcomes, novel therapies with …